Pathophysiology of concentric visual field defect
ELECTRODIAGNOSTICS OF DISEASES WITH
CONCENTRIC VISUAL FIELD DEFECTS
Summary of Ph. D. Thesis
Andrea Pálffy M.D.
Department of Ophthalmology
Faculty of Medicine
University of Szeged
International Society of Clinical Electrophysiology of Vision
nonarteritic anterior ischemic neuropathy
Interpretation of the visual field (VF) is a key part of ophthalmic and neurological
examinations. A VF defect indicates a defect in the retina or in the visual pathways. The damage may affect different locations along the visual pathway, from the optic nerve to the visual centres of the occipital lobes. Beyond characterizing almost all pathological processes in the region, VF defects also help to locate the site of the lesion, as lesions interrupting the function of particular parts of the visual pathway cause specific defects. Thus, perimetric examination may indicate the site and extent of damage to the visual pathway.
The extent of the involvement of the visual pathway may change during the progression of
the pathological process. In cases with concentric VF narrowing and generalised sensitivity disturbances the VF defect can be described according to alterations by retinal quadrants. The depression may be equal or unequal by meridians.
Progression may lead to tunnel vision, by which means a field narrowing yielding 20º or less
residual area on one or both sides is meant. Depending on in which quadrant the larger isopter constriction is found and in which stage of the disease the characteristic field defect turns into no longer specific VF constriction, a problem of differential diagnostics also arises.
For objective detection of the functional alterations in the visual pathway numerous
electrophysiological methods have been developed in the past two decades. These include the standard electroretinography (ERG), multifocal electroretinography (mfERG), pattern electroretinography (PERG), visual evoked potential (VEP) and the multifocal visual evoked potential (mfVEP). The importance of these methods is that the retinal function can be tested in detail, and minimal cooperation of the patient is sufficient to obtain objective data on the function of the retina, the visual pathway and the visual cortex.
The aim of our study was to assess the value of the electrophysiological methods in the
differential diagnosis and in the localisation of the defect in diseases with VF alterations. We sought to determine which electrophysiological method(s) can help the detection of the cause of non-characteristic VF defects, and which combination of methods yields the best localisation of the lesion.
2. General description of methods
2.1. Techniques of visual field testing
There are many methods to evaluate the function of the visual pathways (confrontation
testing, Amsler test, kinetic and static perimetry). The most widely used ones are the kinetic perimetry (Goldmann perimetry) and the automatic, static method (Humphrey-test, Octopus perimetry).
In kinetic perimetry, spots of equal retinal sensitivity in the VF are searched for. By
connecting these areas of equal sensitivity, an isopter is defined. A stimulus of constant size and intensity is used, which is moved from blind to detectable areas of the VF along a meridian. The luminance and the size of the target can be changed to plot different isopters. The larger the size and higher the intensity of the target, the wider the isopter is. This method is the one most widely used in detecting VF narrowing.
In static perimetry we use stationary targets of constant size, but variable intensity. With this
type of perimetry we measure differential light sensitivity for a stimulus presented against a constant background illumination. The threshold of this differential light sensitivity represents the brightness of the stimulus that is actually perceived. Thus, this method indicates retinal light sensitivity at predetermined locations in the VF.
2.2. Electrophysiological methods
Full-field electroretinography reveals the electrical activity generated within the retina in
response to light stimulation. Different conditions of retinal adaptation and stimulus intensity make
the assessment of global function of rod and cone pathways and the functional segregation of different retinal layers possible.
The International Society of Clinical Electrophysiology of Vision (ISCEV) has determined
the standard clinical protocols to facilitate inter-laboratory comparison. An ISCEV standard ERG includes the following responses, named according to retinal adaptation level and the intensity of the stimulus (flash strength in cd·s·m-2): (1) Dark-adapted 0.01 ERG (formerly ‘rod response’) consisting of a negative ‘a’ wave representing the rod function and a positive ‘b’ wave generated mainly by the bipolar cells. (2) Dark-adapted 3.0 ERG (formerly ‘maximal or standard combined rod–cone response’). It is a mixed rod-cone response dominated by rod system function. The negative ‘a‘ wave arises in relation to photoreceptor hyperpolarisation. The large ‘b’ wave reflects postphototransduction or postreceptoral function. (3) Dark-adapted 3.0 oscillatory potentials (OP) (formerly ‘oscillatory potentials’) consist of small wavelets from the ascending limb of the ‘b’ wave of maximal ERG, and they are at least partially generated by the amacrine cells. (4) Light-adapted 3.0 ERG (formerly ‘single-flash cone response’) reflects activity of the cone system. Its ‘a’ wave is generated by the cone receptors and the ‘b’ wave comes from the hyperpolarizing ON and OFF bipolar cells. (5) Light-adapted 3.0 flicker ERG (formerly ‘30 Hz flicker’) arises from the L and M cone pathways, because the S cone system is relatively insensitive to high temporal frequencies.
2.2.2. Multifocal electroretinography (mfERG)
Multifocal electroretinography (mfERG) provides topographic measure of the
electrophysiological activity of the central retina. Using this technique, multiple local cone-driven responses are recorded from the retina under light-adapted conditions.
The pattern of the stimulus contains an array of hexagons (61 or 103), that increase in size
with distance from the centre. The sizes of the hexagons are scaled inversely to the gradient of cone receptor density, so as to produce focal responses of approximately equal amplitude in control subjects. The radius of the central hexagon is 2°. The retinal size of the display subtends 30º in radius, similar to the area tested by standard clinical VFs with automated perimetry. During stimulation, each element is either black or white. During stimulation, the display appears to flicker because each hexagon goes through a pseudo-random sequence (the m-sequence) of black and white presentations. Each hexagon has a 50% chance of being white or black upon each frame change. Every hexagon in the array is driven by the same m-sequence of white and black presentations.
The typical waveform of the basic mfERG response (also called the first-order response or
first-order kernel) is a biphasic wave with an initial negative deflection followed by a positive peak. There is usually a second negative deflection after the positive peak. These three peaks are called N1, P1 and N2, respectively.
The results are displayed as trace arrays, group averages, quadrants and topographic (3D)
response density plots. Trace arrays can produce an array of the mfERG traces. This display of the results is useful for visualizing areas of abnormality.
There is evidence that N1 includes contributions from the same cells that contribute to the a-
wave of the full-field cone ERG, and that P1 includes contributions from the cells contributing to the cone b-wave and OPs. Although there is some homology between the mfERG waveform and the conventional ERG, the stimulation rates are higher for the mfERG, and mfERG responses are mathematical abstractions. Thus, mfERG responses are not technically ‘little ERG responses’.
2.2.3. Pattern electroretinography (PERG)
Pattern electroretinogram (PERG) is a retinal response evoked by viewing a temporally
alternating black and white checkerboard pattern.
The waveform of the PERG depends on the temporal frequency of the stimulus. At high
temporal frequencies, i.e. above 10 reversals/s (5 Hz), the successive waveforms overlap and a ’steady-state’ PERG is evoked. The steady-state PERG waveform is roughly sinusoidal, and interpretation requires measurement of amplitude and phase shift by Fourier analysis.
At low temporal frequencies (<6 reversals per second (rev/s); equivalent to <3 Hz) transient
PERGs are obtained, which are effectively complete before the next contrast reversal, thus allowing separation and interpretation of the components; this is the standard method for clinical practice.
The PERG waveform consists of a small initial negative component (N35), which is followed
by a much larger positive component (P50). This, then, is followed by a larger negative component (N95).
The exact origins of P50 are yet to be ascertained, but it appears partially to arise in relation
to spiking cell function, and partially from non-spiking cells. P50 is driven by the macular photoreceptors and has been used to provide an effective assessment of macular function. There is clinical and experimental evidence to indicate that N95 arises in the retinal ganglion cells.
2.2.4. Pattern visual evoked potential (PVEP)
VEP is an evoked electrophysiological potential extracted from the electroencephalographic
activity of the occipital cortex. It provides important diagnostic information regarding the functional integrity of the visual system.
VEPs can be evoked by flash (flash VEP, FVEP) or pattern stimulation (pattern VEP,
PVEP). FVEP is not sensitive to VA loss, and its intraindividual variability is high. The flashing light stimulates both the parvocellular and the magnocellular pathways. Conduction velocities of these two pathways are different; thus, the responses may have two peaks. This method is applied only when the patient VA is not enough to fixate on the pattern stimulus or patient cooperation is impaired.
In the clinical practice, a black and white checkerboard pattern is used for evoking PVEP.
Field size, pattern size and contrast, retinal area of stimulation, and the rate of pattern presentation can all be varied.
PVEPs are either transient or steady-state. A transient PVEP is to be observed when a
substantial interval elapses between stimulus presentations, allowing the brain to regain its resting state. Steady-state PVEPs are produced when the brain does not regain its resting state between stimulus presentations. The temporal rate at which PVEPs change from transient to steady-state in general occurs at 6-10 presentation per second.
PVEP reflects activity of the sensory visual pathways from the central part of the retina to
the occipital cortex. The projection of the macula is situated on the mesial surface of the occipital cortex. The other reason why PVEP reflects the activity of central retina is cortical magnification. The magnification factor is 5.6 mm/degree at the fovea. The fovea and the parafovea may be selectively stimulated changing the size of the squares. 10-15 min sized squares stimulate the fovea, while the larger 50 min squares stimulate the parafovea.
The PVEP waveform consists of three peaks: an initial negative component (N75), which is
followed by a much larger positive component (P100). This, then, is followed by a smaller negative component (N135).
3. Methods and results
3.1. Techniques of visual field testing
Kinetic VF tests were carried out with a Goldmann perimeter, with a background intensity of
3.15 apostilbs (asb). A III.e white target was moved from blind to detectable areas of the VF along a set meridian. The procedure was repeated with the use of the same stimulus along other meridians, usually spaced every 15°.
Static perimetry was carried out with an OCTOPUS perimeter 1-2-3 (Interzeag AG, Schlieren,
Switzerland). The differential light sensitivity to a stimulus against a constant background illumination was measured.
3.2. Electrophysiological methods
Electroretinograms (ERGs), multifocal electroretinograms (mfERGs), pattern
electroretinograms (PERGs) and visual evoked potentials (VEPs) were recorded with the RETI-
Port 32 system (Roland Consult Gmbh, Wiesbaden, Germany). All of the procedures were performed in accordance with ISCEV standards.
Before the tests, the procedures were fully explained to the patients and their informed
consent was obtained. The research followed the tenets of the Declaration of Helsinki.
In introducing these new methods into the routine clinical practice we determined first the
parameters of the normal values and their variability. Data were analyzed with SPSS 13 software (SPSS Inc., Chicago, USA). The normal data are presented mean, median, standard deviation (SD), percentiles 0.5 and 0.95, and coefficients of variability (CV).
3.2.1. Electroretinography (ERG)
Standard ERGs were studied in 31 volunteers with good vision. Mean age of the subjects was
The pupils of the volunteers were fully dilated with a combination of Mydrum (Chevin,
Ankefarm) and Neosynephrin (10%, Ursaform) solutions before ERG testing.
Dawson-Trick-Litzkow (DTL) electrodes were used as active electrodes. Gold cup
electrodes, 5 mm in diameter, were used as reference electrodes applied 1 cm laterally from the ipsilateral orbital rim, and as a ground electrode, placed over the midline of the forehead (Fz). Sampling rate was 1000 Hz. Impedance was kept below 5 kΩ. Binocular stimulation was used.
ERGs were recorded by Ganzfeld (full-field) stimulator. (1) Dark-adapted 0.01 ERG (rod
response) was measured after a 20 minutes’ dark adaptation. The stimulus was a dim white flash of 0.01 cd·s·m-2; with a minimum interval of 2 s between flashes. (2) Dark-adapted 3.0 ERG (maximal response) was elicited by a white 3.0 cd·s·m-2 flash in the dark-adapted eye. There was an interval of at least 10 s between stimuli. (3) Dark-adapted OPs were obtained from the dark-adapted eye, using the 3.0 cd·s·m-2 flash stimulus. (4) The eye was then restored to photopic conditions (rod-suppressing background illumination of 17-34 cd/m2) and photopic responses were recorded. Light-adapted 3.0 ERG (single-flash cone response) was evoked by a 3.0 cd·s·m-2 stimulus, with at least 0.5 s between flashes. (5) Light-adapted 3.0 flicker ERG (30 Hz flicker) was obtained with 3.0 cd·s·m-2 stimuli. Flashes were presented at a rate of approximately 30 stimuli per second (30 Hz).
The amplitudes and latencies were measured for the interpretation of the ERGs. The a-wave
amplitude was measured from baseline to a-wave trough; the b-wave amplitude was measured from a-wave trough to b-wave peak; the a-wave and b-wave latencies were measured from the time of the flash to the peak of the wave.
3.2.2. Multifocal electroretinography (mfERG)
21 volunteers with good vision were involved in this examination. Their ages ranged from 9
to 72 year with a mean of 33.24 ± 14.9 years. We also analyzed mfERG results obtained in 35 healthy volunteers with good vision. These provided no evidence for the advantage of either binocular or monocular stimulating conditions in obtaining mfERGs.
Volunteers’ pupils were fully dilated with a combination of Mydrum (Chevin, Ankefarm)
and Neosynephrin (10%, Ursaform) solutions before testing.
DTL electrodes were used as active recording electrodes. Gold cup electrodes, 5 mm in
diameter, were used as reference electrodes applied 1 cm laterally from the ipsilateral orbital rim and as ground electrode placed over the midline of the forehead (Fz). Sampling rate was 1000 Hz. Impedance was kept below 5 kΩ.
The screen–patient distance was 28 cm. Subjects had normal or corrected-to-normal VA
(1.0). Binocular stimulation was used, but when we found the area of best responsiveness in an eccentric position, we retested the patient with monocular stimulation and compared the two recordings.
The subject fixated a small central sign in the display containing 61 hexagons. The radius of
the central hexagon was 2°. The retinal size of the display subtended 30º, similar to the area tested by standard clinical VFs with automated perimetry.
During stimulation, each element was either black or white (93% contrast). The mean
luminance was 51.8 cd/m2, whereas the frame rate was 75 Hz. For a 50.000 times’ amplification, the filters were set between 5 and 100 Hz. Typically the recording took about 7 min.
The mfERG responses had three peaks, N1, P1 and N2, respectively. The N1 response
amplitude was measured from the starting baseline to the base of the N1 trough; the P1 response amplitude was measured from the N1 trough to the P1 peak. The peak times (implicit times) of N1 and P1 were measured from the stimulus onset.
3.2.3. Pattern electroretinography (PERG)
PERGs were studied in 68 healthy subjects with good vision. Their mean age was 34.88 ±
14.77 years, with a range of 10-72 years.
The pupils of the volunteers were not dilated before examinations.
DTL electrodes were used as active electrodes. Gold cup electrodes 5 mm in diameter were
used as reference electrodes pasted 1 cm laterally from the ipsilateral orbital rim, and as ground electrodes, placed over the midline of the forehead (Fz). Sampling rate was 1000 Hz. Impedance was kept below 5 kΩ.
The viewing distance was 33 cm. Subjects had normal or corrected-to-normal VA (1.0).
Black and white checkerboard patterns with check sizes of 30’ of visual angle served as the
stimulus. The VF extent of the stimulus display was 12º vertically and 16º horizontally. The contrast of the patterns was 97%. The reversal rate was 2 Hz. Filters were set to 1 and 100 Hz. Two hundred responses were averaged. To test trial to trial variability all tests were repeated in the same session after a break of 2 min.
The PERG waveform consists of a small initial negative component with a peak time of
approximately 35 ms, N35, which is followed at 45–60 ms by a much larger positive component (P50). This positive component is followed by a larger negative component at 90–100 ms (N95).
The implicit time of the peaks and the amplitude values of the N35/P50 and P50/N95 are
determined. The implicit time is measured from the onset of the contrast reversal to the peak of the component. The amplitude measurements are made between peaks and troughs: the P50 amplitude is measured from the trough of N35 to the peak of P50. In some patients the N35 is poorly defined; in these cases N35 is replaced by the average baseline between time zero and the onset of P50. The N95 amplitude is measured from the peak of P50 to the trough of N95.
3.2.4. Pattern visual evoked potential (PVEP)
To determine of normal values of VEP 50 control subjects were tested. Their mean age was
38.48 ± 16.14 years, with a range of 7-72 years.
The pupil of the volunteers was not dilated before examinations.
VEPs were recorded through gold cup electrodes. The recording electrode was placed on the
Oz site, the reference electrode on the Fz site. The ground electrode was placed on the Fpz site. Sampling rate was 1000 Hz. Impedance was kept below 5 kΩ.
The viewing distance of the black-and-white checkerboard stimulus pattern was 33 cm.
Subjects had normal or corrected-to-normal VA (1.0). Monocular stimulation was applied. The VF extent of the stimulus display was 12º vertically and 16º horizontally. The check sizes were 20 and 40’of visual angle. In cases of simultaneous recording of PVEP and PERG the check size was 30’. The contrast was 97%. The reversal rate of the stimulus was 0.9 Hz. Filters were set between 1 and 100 Hz. One hundred responses were averaged. To test trial to trial variability, all tests were repeated in the same session after a break of 2 min.
For the characterization of PVEPs the N75, P100 and N135 implicit times and the N75/P100
4. Clinical studies
4.1. Clinical studies I.: Multifocal ERG reveals several patterns of cone degeneration
in retinitis pigmentosa with concentric narrowing of the visual field
MfERGs of 86 eyes of 43 patients with retinitis pigmentosa (RP) were analyzed. Mean age of
the patients was 31.44 years, within the range of 6-64 years.
Inclusion criteria were as follows: VA at least 0.2 in the worse eye (allowing fixation on the
central cross in the stimulus pattern) and a residual VF of at least 5-10º as detectable by the Goldmann perimetry with the III.4 white stimulus. None of these patients had recordable ERG.
The mfERG alterations were analysed by trace array, ring and quadrant analysis. The results
were compared to control data from 21 normal volunteers. Data were analyzed with a two-way ANOVA for group and for category. When ANOVA showed significant differences, post-hoc analysis was performed with the Dunnett test. P <
0.05 was considered significant.
The three dimensional presentation generally showed a characteristic central peak surrounded
by very small responses in this disease. However, 13 of the 43 patients had not even a central peak. On the basis of the best response density of the mfERGs, the patients were divided into three groups.
Patients in Group I
14) presented typical mfERGs and typical VF constrictions on both
sides. The area of best responsiveness was found to be the 31st hexagon, producing a central peak surrounded by low responses depending on the severity of VF constriction. However, even if the peripheral rings had almost undetectable kernels, one or two ‘good’ responses were almost obtainable in the trace arrays (e.g. 10, 11 or 51). Furthermore, in spite of the characteristic central peak, the mean amplitude values of the 31. kernels were significantly subnormal as compared to the normal control values (mean: 43,06 nV/deg2, range: 17,2-82,2 in patients with RP, and 109, 62 nV/deg2, range 51,3-136 in controls). The differences between these two variables were significant (P<0.00001). In both the control subjects and the patients with RP, the amplitudes of the responses declined rapidly toward the outer rings.
The patients’ mean VA was 0.86, and only three patients had a VA of 0.5 in the worse eye. In Group II
16) the best response was found in the 31st position of the trace array on only
one side. In the fellow eye, the best response density appeared in an eccentric position. This alteration could not be a consequence of a fixation problem, as the fusion phenomenon keeps the eyes motionless during binocular stimulation. No laterality differences were found in the refraction or in the VA. The ophthalmoscopic picture of the macular area was similar in both eyes without any abnormality such as cystoid macular oedema or epiretinal membrane. No history of strabismus or other eye disease could be responsible for these differences. Latent exo- or esotropia was excluded by careful orthoptic examination.
In cases where the area of best responsiveness was found in an eccentric position, we
repeated the stimulation monocularly as well. In both conditions, the best responses were found outside the central position. In this group, the averaged mean amplitudes of the responses in the first ring of the mfERGs were lower than in group I, although some eyes had a very good central peak. Accordingly, we analyzed the mfERG findings of this group in two subgroups, depending on the site of the best responses. Group II.A comprised the mfERGs of the eyes with a central response, and group II.B of those of the fellow eyes with an eccentric best position. The amplitudes of the responses in the first ring of the group II.A eyes (mean, 47.41 nV/deg2) were almost the same as those in group I. The eyes with eccentric best responses (group II.B) produced lower amplitudes in the first ring (mean, 24.36 nV/deg2). No significant side differences between the two eyes were found in the amplitudes of the third, fourth, and fifth rings or in the four quadrants.
The patients in group II had a mean VA of 0.65. Altogether, 25 of the 32 eyes exhibited VA
The patients in Group III
=13) presented no central peak in the mfERG on either side.
These cases were classified in earlier studies as ‘undetectable mfERGs’ or as artefacts. However, in some parts of the trace array, we found satisfactorily intact responses in all these patients. In these plots, the best responses were found at rather variable sites (e.g., hexagons 17 and 47). In some cases, there were two or three peaks of low amplitude in the three-dimensional presentation of scalar products, making them ‘uneven’, ‘patchy’ in appearance, or ‘unrecordable’. The mean amplitude in the first ring of the mfERGs in this group was rather low (19.28 nV/deg2). The
appearance of some characteristic, though small, responses convinced us that these mfERG recordings could not be attributed merely to artefacts or noise. Repeated examinations gave almost corresponding results.
These patients also had satisfactory VA (0.9–0.2, mean, 0.4). Three eyes had a VA of 0.9,
and 12 one had 0.5 or better (0.7– 0.5).
4.2. Clinical studies II: Pattern-reversal electroretinograms and visual evoked potentials
in retinitis pigmentosa
To determine PERG and VEP in RP patients 106 eyes of 53 patients with different
inheritance and durations of RP were analyzed. The age-matched normal values were calculated by taking into account the PERG parameters of 114 eyes of 57 subjects and the PVEP parameters of 146 eyes of 73 subjects with good vision and without any ophthalmological or systemic disease.
To determine PERG alterations, the N35, P50 and N95 peak times and the N35/P50 and
P50/N95 amplitudes were measured. For the characterization of PVEPs the N75, P100 and N135 implicit times and the N75/P100 and P100/N135 amplitudes were measured. The waveform alterations of PVEP were regarded as having double P100 peaks if two positive waves appeared in this interval with a negativity of at least 1 μV. The amplitudes between the larger positive peak and N135 (Pmax/N135) were used to express the magnitude of the deflection, independently of whether P1 or P2 was the larger. The broadness of the response was characterized by the latency differences between N135 and N75.
Statistical analysis was performed only on recordable, reproducible responses. Data are
presented as means ± SD. The results were analyzed by a one-way ANOVA. Subsequent analysis was performed using Newman-Keuls test. A p-value less than 0.05 was considered significant. Data were analyzed with STATISTICA 7.1. software (Statsoft Inc., Tulsa, OK).
Seventeen of the 53 patients (32%) yielded recordable, reproducible PERGs. Of these 17
patients, 4 yielded reproducible PERGs from only one eye. Both the N35/P50 and P50/N95 amplitudes of the PERGs were significantly smaller than those of the controls. We failed to record a normal PERG from any of the patients.
All 53 patients yielded PVEPs which fitted the criteria of reproducibility, though
characteristic alterations were detected in some cases. Depending on the type of these alterations, we divided the patients into three groups. No statistical correlation was found between this division and the age or the duration of RP or the extent of the VF defect in the patients.
The PVEPs in the three groups exhibited certain characteristics as follows.
All the patients in Group I
(n = 17; 32%)
had PVEPs with a normal shape. These PVEPs
revealed significantly smaller amplitudes in comparison with the age matched control group. The peak time of the P100 components was slightly delayed in a few cases, but no longer than 120 ms. The N135 peaks were at times slightly delayed too, but this alteration did not reach the level of significance. The interindividual variability of the amplitude of the PVEPs was rather large.
There was no direct correlation between the decrease in amplitude and the age of the patient
or the amplitude and the estimated duration of the disease. In this group, subnormal PERGs were recorded in 14 eyes, while they were extinguished in 20 eyes.
The VF constriction assessed via the Goldmann perimeter varied in severity (5º–20º). The
upper and lower parts of the field in these patients displayed almost the same degree of constriction. In some cases, a 5º–10º VF crescent was preserved in the temporal lower part of the far-peripheral field, close to 90º.
In Group II
(n = 16; 30%), the PVEPs had a characteristic, bifid pattern and the recordings
demonstrated well-defined, doubled P100 peaks (P1 and P2). The two components of P100 were separated by about 50 ms. In 6 patients P1 was the larger, while in another 6 cases P2 was the larger, and in 4 cases there was no difference in amplitude between the two peaks. The double peak or ‘W’ form, of the P100 peak may lead to confusion in the interpretation and in the statistical analysis. It appeared inappropriate to presume that one or the other was ‘the true’ P100. To express the absolute size of the deflection, not only the N75/P100 amplitude, but also the Pmax/N135 components were determined. The decrease in amplitude and the lengthening of the implicit time
of P1 were moderate, but both values revealed a significant difference as compared to the controls. However, the P2 latencies were rather long and the N135 latencies were greatly delayed. In several cases, the N135 latency was longer then 200 ms. The inter-peak time of the negative components (N135 and N75) were significantly longer than those in the controls. The Pmax/N135 amplitudes were significantly larger than the N75/P100 amplitudes in this group and than the P100/N135 amplitudes in the two other groups of our patients. This resulted in the characteristic asymmetrical shape of the curves. Furthermore, the N135/N75 latency differences were significantly larger than those of the controls and those observed in Group I.
Subnormal PERGs were recorded in 14 eyes, while the PERGs were extinguished in 18
cases. Similarly to Group I, Goldmann perimetry revealed a concentric narrowing of the field, with preserved central part. Several patients exhibited the substantial narrowing in the upper hemifield that approached the central 5º but never involved it. In 14 eyes of the 16 patients, 5–15º of the fields was intact; in the remainder (18 eyes), the central 20º of the VF was preserved.
All the recordings in Group III
(n = 20; 38%), (40 eyes of 20 patients) revealed a serious
impairment, albeit they were reproducible. They had a delayed implicit time, and most of the recordings had decreased amplitudes. No true doubled peaks with P1 and P2 could be separated, although the waveform was broad and sometimes very flat. Not only the P100, but also the N75 and N135 latencies were significantly delayed. It is worth noting that the latency differences between the N135 and N75 peaks were significantly longer than in the normal controls.
There were no strict correlations between the VA and the PVEP parameters or VF loss, since
some patients in this group exhibited sufficient VA. However, the mean visual acuity in Group III was only 0.4. Only 4 eyes of 2 patients yielded recordable, reproducible PERGs. Upon Goldmann perimetry, the field in 20 eyes was constricted up to 15–20º, while in the rest there was only a field-remnant of 5º to 10º.
4.3. Clinical studies III.: Melanoma associated retinopathy (MAR) syndrome
Case history and clinical symptoms of a monocular case with MAR syndrome is presented.
A cutaneous malignant melanoma was removed from the left leg of a 45-year-old woman in
1992. Because a systematic search revealed no metastasis, no further therapy was administered.
One evening in January 2000, she suddenly experienced difficulty seeing in dark conditions
through her right eye, which greatly interfered with her stereovision. She also reported shimmering lights that fluctuated in brightness.
Because an ophthalmological examination demonstrated good VA and no fundus alterations,
the patient’s complaints were judged to be of psychic origin. Four months later, a metastatic cutaneous melanoma was removed from her left leg. She underwent chemotherapy and was referred to our electrophysiological laboratory because of her persisting visual complaints.
She still had a best-corrected VA of 20/20 on both side. Static perimetry (Octopus) revealed a
marked VF constriction and a general depression of light sensitivity in the right eye. The left eye exhibited no perimetric alterations.
The single-flash ERG showed a markedly decreased scotopic response in the right eye,
whereas maximal-intensity stimulation elicited a typical ERG that showed no abnormalities, a selective b-wave depression with a preserved a wave. Both the scotopic rod-isolated response and the maximal response in the left eye were in the normal range. The averaged ERG and OPs were greatly impaired in the right eye but normal in the left eye.
Serum immunochemistry revealed strong binding to retinal bipolar cells, similar to that of a
known patient with MAR. This result supported the diagnosis of MAR, so our case was the first monocular case of this disease.
Five control electrophysiological examinations together with perimetry and ophthalmoscopy
showed no changes during the following 15-month observation period. Unfortunately, the patient died in August 2001. The family did not allow an autopsy.
4.4. Clinical studies IV.: Diseases with visual field narrowing
Clinical studies IV/A.: Electrophysiological findings in patients with
nonarteritic anterior ischemic optic neuropathy (NAION)
Beside VF testing (Goldmann kinetic perimetry), standard ERGs, mfERGs, PERG and VEP
were performed for the objective evaluation of the severity of the functional loss in 8 NAION patients.
The diagnosis was based on the history and symptoms: a sudden visual loss or VF loss, optic
disk oedema followed by pallor of the disk, a relative afferent pupillary defect, altitudinal VF defect with narrowing the isopters (in all four retinal quadrants).
An intracranial cause of the visual loss was excluded by careful neurological examination,
intracranial and orbital MRI and CSF analysis. Other pathologies of disk oedema such as vasculitis, syphilis, borelliosis, herpes simplex, etc. were excluded by serological and immunological tests. Colour Doppler ultrasonography ruled out intracranial circulatory disturbances.
VEPs revealed a serious deterioration in most of the patients. This was especially marked in
3 cases (Cases 4, 5 and 6) where diabetes mellitus (DM) was the underlying disease. All of them had rather poor VA. Similarly, the VEPs showed a considerable amplitude reduction and prolonged P100 peak time upon stimulation of the impaired eye in the two monocular cases (Cases 7 and 8). A prolonged P100 implicit time was also the characteristic VEP alteration in the 3 patients with hypertension (Cases 1, 2 and 3). Interestingly, the VEPs of the non-involved eyes of the two monocular cases had delayed implicit time, too.
tests were carried out for statistical comparison. An age-matched group of 26
healthy individuals with good vision without any ophthalmological and systemic disease served as normal controls. Statistical comparison of the amplitude and implicit time values of the VEPs in patients with NAION and of the age matched normal controls revealed a significant increase in the implicit time of P100 (P<0.001) and a significant reduction in the amplitudes between N75 and P100 (P=0.0001) and in those between P100 and N135 (P=0.0005).
The PERG recordings did not show major abnormalities. There were no statistical
differences between the implicit time values of the patients and the controls, whereas some amplitude reduction was observed in most cases. Accordingly, statistical comparison of the amplitudes of the PERGs in patients and controls revealed significant differences (N35–P50: P<0.0005; P50–N95: P<0.00003). These values, however, mostly lay in the range for the age matched normal group. No selective P50–N95 amplitude reduction was found. The quotient of the P50–N95 amplitudes over the N35–P50 amplitudes of the patients (1.32±0.32) was not statistically different from that for the normal individuals (1.29±0.17). It was noteworthy, however, that the patients with DM and rather poor vision had better PERGs than those with hypertension. Patients with old age and long duration of hypertension had the most severe PERG alterations. No side differences were observed in the PERGs of the monocular cases.
In general, the most striking observation was that patients with poor VA did not have worse
MfERGs had no obvious alterations in the patients.
4.4.2. Clinical studies IV/B.: Nonarteritic ischaemic optic neuropathy (NAION) in
patients under 50 years of age
NAION is a rather frequent cause of sudden visual loss in elderly patients. However, we
found three patients with diabetes, who had the first ischemic attack under the age of 50. We describe their case histories, clinical and electrophysiological findings.
For objective evaluation of the optic nerve function, visual evoked potentials (VEPs) were
recorded, whenever a recurrent event of visual loss or progression of visual impairment was reported.
Intracranial pathological alterations were excluded in all cases by careful neurological
examinations, including CSF examination and cranial and orbital MRI testing (1.5 T; General
Electric, Fairfield, CT, USA). Clinical laboratory tests for diseases that could cause optic neuritis or vasculitis (erythrocyte sedimentation rate, blood cholesterol level, complete blood count, antinuclear antibody, rheumatoid factor, C-reactive protein, venereal disease research laboratory test, herpes, toxocara, IgG in CSF) were routinely performed according to the general condition of the patient.
A 35-year-old woman had suffered from insulin-dependent DM from the age of 22
years. Four years prior to this study, she noticed that the vision in her right eye had suddenly become blurred. A visual impairment was detected not only in the right eye, but also in the left. VA was 0.5 in the right eye and 0.4 in the left eye. The temporal parts of both optic discs were pale, and the nasal superior quadrant of the right disc was oedematous. Goldmann perimetry showed an enlarged blind spot and a VF defect in the nasal inferior quadrant of the right eye and concentric narrowing of the isopters in the left eye.
The patient’s young age supported the presumptive diagnosis of multiple sclerosis. However,
fat-suppressed, T1 and T2 sequenced brain and orbital MRI, somatosensory evoked potential and VEP, and CSF immune tests showed normal results. Intracranial circulation disturbances could be excluded by the normal results of colour Doppler examination of the internal carotids and the ophthalmic artery. Chemical analysis of the CSF and blood, serological tests for syphilis, borelliosis, herpes simplex infection and other immune tests yielded normal results. The presence of any other systemic diseases that might cause vasculitis was excluded as well. Nonetheless, the subject’s neurologist put her on steroid treatment.
The next attack of visual impairment occurred 2 years later. VA in the patient’s left eye
decreased to 0.15. Repeated MRI examination failed to show any pathological signs. The patient was treated with steroids again, without any success. VA remained 0.15 in both eyes. VF defect covered the central part.
One year later, the subject suddenly lost almost all vision in her left eye. The pupillary light
reflex was sluggish and hardly elicitable.
No further recurrence of visual impairment was observed in the right eye. VA was 0.15 in the
right eye and light perception in the left. Both optic nerve heads presented a milky-white appearance. The VFs did not reveal any change in the defects in the right eye (peripheral constriction and central scotoma), while testing was not performed in the left eye because of the serious visual loss. The patient underwent repeated orbital and cranial MRI and laboratory examinations that consistently provided evidence against multiple sclerosis, acute optic neuritis or vasculitis.
A 50-year-old woman had DM for 12 years. Ten years prior to this study, at the age
of 40 years, she noticed progressive visual disturbance in her right eye. The progression of the central visual loss lasted for only 3 days, but the narrowing of the VF continued for the following 2 weeks.
The subject’s VA was 0.15 in the right eye and 1.0 in the left. The right optic disc had an
oedematous swelling, whereas the left was normal. No signs of diabetic retinopathy were observed. The temporal part of the VF in her right eye was constricted to 35º, while the VF in the left eye remained normal.
Upon neurological examination, the MRI was found to be normal and the laboratory tests did
not indicate any other pathology than diabetes and hypertension. Thiogamma (600 mg/day) was also administered because diabetic neuropathy was suspected to be the cause of the visual loss.
No change in VA or VF occurred during the subsequent year. Two years later, the patient
suddenly lost vision in the left eye. Her ophthalmologist registered VA of 0.15 in the right eye and 0.08 (finger counting from a distance of 4 meters) in the left. The right optic disc was pale and the left was oedematous. The possibility of Foster–Kennedy syndrome, as a consequence of the intracranial pathology, was again excluded. No other symptoms have appeared since then. Her vision has never recovered: VA remains at 0.15 in the right eye and 0.1 in the left. Both optic nerve heads have become atrophic. No diabetic retinopathy has developed. Her VF defects have changed during the past 2 years. No reproducible VEPs could be detected.
A 51-year-old woman had non-insulin dependent DM for 12 years. At the age of 42,
she noticed a progressive visual deterioration in her left eye, which at that time was ascribed to cataract formation. In the left eye, the retina was obscured by lens opacification. The VA was 0.4, which seemingly correlated well with the condition of her lens. Cataract surgery was performed. However, no improvement of vision was detected thereafter. Best corrected VA was 0.04. The head of the optic nerve was pale.
The right eye similarly exhibited signs of cataract formation. The appropriate surgery resulted
in a VA of 0.6. Seven months after surgery the subject’s vision in her right eye had decreased to 0.1. Only a mild optic disc oedema was observed, which turned to optic atrophy within 2 months. Again, no signs of diabetic retinopathy were found. The VFs displayed a marked constriction of up to 15–20º in the right eye, while only a paracentral remnant of the VF could be detected in the left eye. No VEPs could be recorded.
Beside NAION no alternative explanation could be found for the subject’s sudden visual loss.
No neurological signs were present and the cranial and orbital MRI excluded multiplex sclerosis. Chemical blood tests and all immunological tests excluded other pathologies of visual loss.
4.5. Clinical studies V.: Differential diagnosis of concentric visual field defects using
128 eyes of 72 patients with concentric VF defect were analyzed in our laboratory between
January 1st, 2002 and 31st December, 2005. The patients’ clinical and electrophysiological data were analyzed retrospectively. Mean age was 47.6 years with a range of 11–75 years.
Ophthalmological examination included assessments of appropriate VA, refraction and
intraocular pressure. Slit-lamp examinations, ophthalmoscopy, and Goldmann perimetry were carried out as well. Electrophysiological examinations (VEP, PERG and ERG) were recorded according to the ISCEV standards.
The results were compared to control data from 58 healthy, age matched control subjects with
The implicit time and the amplitude of the VEP, PERG and ERG waves were analyzed.
Data were analyzed with two-way ANOVA. P <
0.05 was considered significant.
Among the 72 patients 20 RP, 1 choroidal osteoma, 1 MAR, 2 optic nerve melanocytoma, 11
NAION, 4 dysthyroid ophthalmopathy, 4 toxic neuropathy, 1 diabetic neuropathy, 9 cerebrovascular circulatory disturbances, 5 optic nerve compression caused by intracranial tumors and 7 empty sella syndrome were found. The possibility of malingering had arisen in 3 cases. Although we found electrophysiological alterations in 4 cases, the aetiology remained unclear.
The decrease of retinal function in RP patients was detected by the extinguished scotopic and
maximal ERG. We found residual responses only in four cases, that time the implicit time of the OP was delayed and its amplitude was decreased. Examining the VEPs, we found both normal, and altered answers with pathological wave form, delayed implicit time and decreased amplitude.
The choroidal osteoma of the papillomacular bundle caused choroidal atrophy in the right eye.
Both the latencies of the VEP and PERG were markedly delayed, and the amplitude of the VEP was diminished. We did not find any choroidal atrophy in the left eye; however, a concentric VF defect developed in this side, too. The implicit time of the VEP was slightly delayed and the amplitude slightly decreased.
During the 13-years observation period of the melanocytoma in the right eye of our patient the
VA decreased, and her VF narrowed. The implicit time and amplitude alterations of the VEP deteriorated, and the implicit time of OP delayed, too.
Decreased VEP amplitude was found in toxic neuropathy. Our diabetic patient’s neuropathy was detected by the VEP, and her maculopathy was
diagnosed by the delayed latency of the PERG and the OP.
We did not found any pathological alterations among patients with endocrine orbitopathy.
General depression or peripheral contraction of the VF can occur in several disorders along the
visual pathways; however, psychogenic and technical factors should also be taken into consideration.
Concentric VF defect can be caused by diseases of the retina, the optic nerve, the optic tract
and the visual cortex. The pathomechanism of the VF constriction differs in these diseases. The electrophysiological examinations can help the diagnosis in questionable cases.
Primary chorioretinal / Photoreceptor dystrophies
is caused by the XL-R inherited mutations in thene
resulting in a diffuse atrophy of the RPE and the choriocapillaris. The first symptom manifesting in males in early childhood is usually impaired night vision followed by a progressive narrowing of the field of vision (tunnel vision), and later a decrease in the VA. The ophthalmologic features are characteristic; however, the field constriction and the progression of the VA resemble the RP. The ERG, VEP and mfERG alterations reveal the exact severity of the disease.
is a rare, AR disorder resulting from the deficiency of the mitochondrial matrix
enzyme ornithine-aminotransferase, the gene of which is located on chromosome 10q26. The exact mechanism of chorioretinal degeneration remains unknown.
Clinically, gyrate atrophy patients initially develop myopia and reduced night vision, usually
before the end of the first decade of life. Ophthalmoscopy reveals the presence of numerous sharply demarcated circular areas in the peripheral retina which gradually increase in number and size, coalesce, and spread from the peripheral to the central fundus, forming lesions with a "gyrate" or garland-like border. Reduced peripheral vision with constriction of the VFs is obvious in the 2nd decade. Complete loss of vision is associated with involvement of the macula. ERG abnormalities are already present at an early stage of the disease, with impaired rod and cone responses, progressing to an extinguished response.
In high myopia
the VF constriction depends on the severity of peripheral degeneration and the
ERG turn to be subnormal. However, we can differentiate between this peripheral retinal degeneration and the true degenerative myopia, which is a retinal dystrophy accompanied with myopia. In this case the ERG is extinguished.
The term of retinitis pigmentosa
(RP) refers to a heterogeneous group of inherited
photoreceptor dystrophies characterized by AD, AR and XL-R inheritance patterns, in which the rods and cones undergo progressive degeneration. Over 100 genes can cause RP. The ‘final common pathway’ remains photoreceptor cell death by apoptosis. This occurs mostly in the mid-periphery of the retina, or, in some cases, the inferior retina, thereby suggesting a role for light exposure.
Affected patients report impaired dark adaptation, night blindness and peripheral vision loss.
Although initially there may be only a peripheral ring scotoma, typically from 30° to 50°, with time this scotomatous area breaks out of the periphery and infringes on the central field, until only a small area of vision remains, sometimes associated with a temporal island.
ERG may be severely subnormal or undetectable as soon as in the early stage of the disease.
For the follow- up of the progression of the photoreceptor loss, PERG, VEP and mfERG seemed to be appropriate.
The PVEPs are elicited predominantly from the central 10º of the VF, which is well preserved
for a long period during the progression of RP. This is why we offer the VEP tests for evaluation of the progression of the disease. Three types of VEP waveforms were found: normal VEPs, VEPs with bifid pattern and VEPs with broad waveform. These alterations might be reflecting different patterns of the cone receptor loss in the central retina. It may depend on the type of inheritance, the time of the examination, etc. The interpretation of these VEP alterations needs further investigation.
PERGs were severally depressed in all of our patients. Following the photoreceptor loss,
transneural degeneration of the ganglion cells can be expected. However, histological examination did not find significant difference in the number of ganglion cells in RP patients with serious or mild visual loss. This result suggests that the visual impairment in RP is determined not only by the extent of degeneration, but also by the localisation of the degenerated patches within the foveal area. This
concept is in agreement with our mfERG observations, which revealed involved and intact areas in the central retina.
According to our observations, mfERG can show the involved and intact retinal areas in the
central 30º of the VF. The different preserved areas in the two eyes may be complemented in the visual cortex (filling-in phenomenon), which can help visual processing. VEP and PERG alterations in RP are important in the follow-up of the progression.
Further investigations into transneural degeneration are very important for any prospective
In cancer- and autoimmune-associated retinopathies
autoantibodies directed at various retinal
protein antigens cause progressive vision loss. An underlying malignancy places this condition in the category of paraneoplastic syndromes. When no malignancy is found, patients are considered to have autoimmune retinopathy.
Recoverin, alfa-enolase and photoreceptor cell-specific nuclear receptor gene product initiate a
cascade of events, leading to increased phosphorylation of rhodopsin, which activates apoptotic pathways, resulting in diffuse photoreceptor degeneration with or without inflammation. Ganglion cells and retinal vasculature are spared. Patients with MAR have IgG autoantibodies that react with human rod bipolar cells antigens.
In cases of CAR, vision loss can occur before malignancy is diagnosed. In contrast, MAR
usually develops years after removal of a malignant melanoma of the skin, often at the stage of skin malignant melanoma metastatic spread.
Symptoms and signs depend on which retinal elements are affected. CAR affects both rods and
cones. Patients with CAR usually have prominent involvement of central vision, resulting in markedly decreased VA, loss of colour vision, and central scotomas. Later total blindness develops. In contrast, patients with MAR, when antibodies against bipolar cells interfere with rod function, often have near-normal VA, colour vision and central VFs. Peripheral or mid-peripheral field loss can usually be demonstrated. Generally, there is no ophthalmologic sign of the disease. Later on, attenuation of the arterioles with thinning and mottling of the RPE may develop.
The ERG alteration (extinguished in CAR syndrome, negative type ERG in MAR syndrome)
can draw the attention to the origin of the sometimes unusual symptoms.
has been suggested as a specific complication of diabetes, but its nature and
pathogenesis are still unclear. Proposed pathophysiological mechanisms include toxic effects of prolonged hyperglycaemia, increased susceptibility of the optic nerves to inflammation in diabetes, a disturbance of schwann cell metabolism, and AION (or vascular pseudopapillitis). Beyond optic neuropathy, peripheral neovascularisation can also result in VF narrowing.
Ganglion-cell, axon- and optic nerve lesions
The diagnosis in glaucoma is
based on the ‘typical’ VF defects caused by pressure differences
between the intraocular fluid and CSF (rather than the absolute value of the IOP). This difference
results in a passive neuronal intracellular fluid flux in the axons of the ganglion cells close to the
lamina cribrosa. The location and the thickness of the axons within the optic nerve at the level of the
lamina cribrosa determine their sensitivity and susceptibility to damage.
Intracellular fluid flow
locally depletes adenosine triphosphate, disrupting active axonal transport, leading to cell death in
The papillomacular bundle of optic nerve axons, - which, as part of the parvocellular pathway,
serve central vision - remain intact for long. PERG is the only objective method for the detection of the ganglion cell damage. During progression more and more axons and ganglion cells will be damaged, resulting in peripheral narrowing of the VF. Glaucoma will cause magnocellular pathway damage.
Nonarteritic anterior ischemic optic neuropathy
(NAION) is one of the most frequent causes
of sudden visual loss in middle-aged or elderly patients. Its annual incidence has been estimated to be 10.3 per 100,000 individuals aged 50 years or older. It was be presumed that an infarction of a blood vessel supplying the intrascleral portion of the optic nerve is the cause of the sudden visual loss. The infarction may occur by defective autoregulation, while others have emphasized the
importance of an anatomical variation of the optic disk (‘disk at risk’) as an important predisposing factor. The acute hypoxia of the optic nerve head results in axoplasmic flow stasis in the optic nerve fibers, swallowing the axons in the level of the cribriform plate of the disk. The fall of perfusion pressure in the optic disc capillaries due to nocturnal arterial hypotension and elevation of IOP results in marked ischemia and that precipitates visual loss, which is usually discovered when waking up in the morning.
The type and severity of the axon loss can be evaluated by VF examination, provided that the
VA is good enough for fixation. In the acute stage it can be an arcuate defect, but later all the four quadrants of the VF can be constricted resulting in an indefinite concentric defect.
Electrophysiological examination shows the severity of the axon damage and in young
patients – when the manifestation of this disease is rare –, thus helping differential diagnosis.
Arteritic ischemic optic neuropathy
(AION) is a sight-threatening autoimmune disease caused
by giant cell vasculitis of the medium arteries. We stress the importance of differentiation between AION and NAION because of their different treatment and prognosis. Blindness can occur by central retinal artery occlusion or ischemic optic neuropathy.
can be caused by exogenous or endogenous factors. If
the subchiasmatic part of the optic nerve is the site of the damage, bilateral central scotomas or a narrowing of the peripheral VF will develop. VEPs are subnormal in these cases, while ERGs are normal.
There are drugs
(thioridasine and indometacinum) which cause RPE lesion followed by
depigmentation and atrophy of the retina. ERGs are subnormal or extinguished in such cases.
Vigabatrin can cause retinal cone dysfunction. An idiosyncratic drug reaction within the
neurosensory retina may underlie the pathogenesis of the VF loss with interindividual susceptibility. Vigabatrin causes irreversible inhibition of GABA aminotransferase with consequent elevation of GABA. Sildenafil (Viagra), vardenafil and tadalafil are selective inhibitors of cyclic guanosine monophosphate specific phosphodiesterase 5. Phosphodiesterase 6 isoenzyme is found predominantly in retinal photoreceptors and is very important in the phototransduction cascade.
Tobacco, alcohol, chloramphenicol and ethambutol cause ganglion cell loss. The pathogenesis
of tobacco–alcohol amblyopia remains elusive; combined mechanisms of toxic insults from tobacco compounds and/or ethyl alcohol might be at play, concurrent with nutritional deficiencies. Tobacco-derived compounds including reactive oxygen species and cyanide reduce mitochondrial respiratory activity, damage mitochondrial DNA, and induce alterations of mitochondrial morphology.
Chloramphenicol is well known to inhibit mitochondrial protein synthesis, causing retinal
ganglion cell and nerve fiber loss, with demyelination of the optic nerve, involving predominantly the papillomacular bundle.
Ethambutol might interact with Cu-containing cytochrome oxydase c (complex IV) and Fe-
containing NADH:Q oxidoreductase (complex I), thus damaging the mitochondrial respiratory chain, inducing axonal swelling in the optic chiasm and in the intracranial portion of the optic nerve.
Tetracycline, minocycline, lithium, Accutane, nalidixic acid, and corticosteroids (both use and
withdrawal) can cause benign intracranial hypertension and papilledema.
In compressive optic neuropathy
, beside the direct compression that the tumor exerts on the
optic nerve, a general intracranial pressure elevation has to be taken into account. Peripheral axons will suffer the direct effect of compression and disturbances of the axoplasmic and blood flow.
- sarcoidosis, tuberculosis, cryptococcus infection, leukaemia,
lymphoma, and metastatic cancer) can also result in VF narrowing.
The disc swelling in papilloedema
is the result of axoplasmic flow stasis with intra-axonal
oedema in the area of the optic disc. The subarachnoid space of the brain is continuous with the optic nerve sheath. Thus, as the CSF pressure increases, the pressure is transmitted to the optic nerve, and the optic nerve sheath acts as a tourniquet to impede axoplasmic transport. This leads to a buildup of material at the level of the lamina cribrosa, resulting in the characteristic swelling of the nerve head.
Bilateral occipital infarct (with macular spare of the centrum)
The posterior cerebral artery supplies the visual cortex. There are many causes of the bilateral
posterior cerebral artery occlusion
: multiple emboli from a mural thrombus of the vertebral or basilar artery, etc. The visual cortex has a secondary blood supply from the carotid system. In infarction of both occipital lobes, the accessory blood supply from the carotid system may preserve the macular projection. A person with bilateral occipital infarct with macular sparing will present with a preserved central acuity but only a small field, usually 2 to 3°, which means functional blindness.
Functional field defects
Patients with functional VF loss
can be placed into one of three general groups: neurasthenics,
hysterics, or malingerers. The neurasthenic patient usually has many complaints, not limited to the visual system, or to the field loss. The degree of field or visual defect varies from one examination to another, sometimes during the examination as well. The patient with hysteria has a single ocular complaint. The malingerer may be the most difficult patient with functional loss, particularly if he has previously been examined by another physician, and has acquired more experience with field testing than he had when first examined. Severely contracted VFs can also be seen in exacting patients who want to be sure they see the object and, therefore, unduly contract the fields. The PVEP is useful to determine the organic origin of the visual loss.
Several diseases causing lesions along the visual pathways can result in concentric VF defect.
In the discussion we collected these diseases and analysed the possible pathological processes that may result in VF defects. The aim of our investigation was to find the appropriate electrophysiological method or combination of methods for objective evaluation of the functional loss in these disorders.
For this purpose the first step was to introduce the modern, standard electrophysiological
methods into the clinical practice in Hungary. I. We determined the normal parameters of standard ERG, mfERG, PERG and PVEP and
II. We drew attention to the importance of combined use of electrophysiological methods,
especially in the neuroophthalmological practice.
III. We observed three types of mfERG alterations in RP. Further we found better preserved focal
areas within the central VF. The mfERG results were against the continuous degeneration of the photoreceptors towards the fovea. These where better preserved areas in the central retina, which may help the analysis of the visual information in the visual cortex in patients with RP.
IV. Although ERG examinations have priority in the diagnosis of RP, we point to the importance of
PERG and PVEP tests in the determination of the progression of the disease. The three types of VEP alterations may reflect not only the severity of the functional loss in the foveal area but may indicate histological different photoreceptor damage, too.
V. We were the first to publish a monocular case of MAR syndrome. VI. Our investigation in NAION patients was important not only in the evaluation of the severity of
visual deficits, but also provided further help to solve differential diagnostic problems in young patients with acute visual loss with papilledema.
The electrophysiological investigations are not widely used in the ophthalmological practice,
although they are the methods to objective evaluation of the functional loss along the visual pathway.
Different disorders resulted in concentric VF loss. The combined use of this methods help to
find the origin of the field loss, help to differential diagnosis in the cases when clinical symptoms, the visual loss and the ophthalmoscopic alterations are not in agreement.
This new methods may give new information on the pathophysiology of the disorders of visual
I am indebted to Prof. Dr. Márta Janáky, Prof. Dr. György Benedek and Prof. Dr. Lajos
Kolozsvári who provided me a chance to participate in this research.
I also thank Kati Mayer and Gabriella Dósai-Molnár for their valuable technical assistance.
List o full papers directly related to the subjects of the Thesis:
1. Janáky M, Pálffy A,
Kolozsvári L, Benedek Gy:
Archives of Ophthalmology
2002; 120: 866-67.
2. Janáky M, Fülöp Zs, Pálffy A
, Benedek K, Benedek Gy.:
Acta Ophthalmologica Scandinavica
2005; 83: 499-503.
3. Janáky M, Fülöp Zs, Pálffy A
, Benedek K, Benedek Gy:
2006; 117: 1158-66.
4. Pálffy A
, Szilágyi M, Benedek K: Differential diagnosis of concentric visual field defects
using electrophysiological methods. Szemészet
2006; 143: 64-68.
5. Janáky M, Pálffy A
, Fülöp ZS, Szabó Á, Gyetvai T, Liszli P: Differential diagnostics of
nonarteritic anterior ischaemic optic neuropathy (NAION). Szemészet
2006; 143: 17-21.
6. Janáky M, Pálffy A
, Deák A, Szilágyi M, Benedek Gy:
Investigative Ophthalmology and Visual Science
2007; 48: 383-89.
7. Janáky M, Pálffy A
, Horváth Gy, Tuboly G, Benedek Gy:
Advances in ophthalmology 2008; 117: 27-36.
8. Pálffy A
, Janáky M, Fejes I, Horváth G, Benedek G: Interocular amplitude differences of
multifocal electroretinograms obtained under monocular and binocular stimulation conditions Acta Physiologica
(Accepted to publication)
Papers not related to the subject of the Thesis:
1. Janáky M, Pálffy A
, Deák A, Gallyas É, Benedek Gy: Electrophysiological screening of
hereditary diseases in myopic patients. Szemészet
2002; 139: 217-221.
2. Pálffy A
, Gyetvai T, Janáky M, Kolozsvári L: Bilateral metastases of breast cancer – case
2003; 140: 259-62.
3. Janáky M, Pálffy A
, Fülöp Zs, Szabó Á, Gyetvai T, Liszli P: Paraneoplastic syndromes of
the retina. Description of a case of melanoma-associated retinopathy. Szemészet
2003; 140: 37-41.
4. New chapter in the study of visual evoked
potentials - clinical application of the multifocal VEP method. Ideggyógyászati Szemle
2004; 57: 377-83.
5. Janáky M, Pálffy A
, Benedek K, Benedek Gy: New chapter in visual evoked potential
studies: Clinical application of the multifocal VEP method. Ideggyógyászati Szemle
2004; 57: 377–83.
6. Gyetvai T, Pálffy A
, Vízvári E: Postoperative endophthalmitis: a 6 year-review. Szemészet
7. Benedek K, Pálffy A
, Bencsik K, Fejes I, Rajda C, Tuboly G, Liszli P
2008; 61: 33-41.
SALIX PHARMACEUTICALS, INC. PRESS RELEASE Salix Pharmaceuticals Announces License Agreement for a New Extended Intestinal Release Formulation of Rifaximin EIR (Extended Intestinal Release) Formulation of Rifaximin to be Studied for Crohn's Disease RALEIGH, N.C.--)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Alfa Wassermann S.p.A. today announced that they have entered into
Exelon Corporation GUIDELINES FOR 2004 DIVERSITY METRICS Basic Premises The 2004 Diversity Metric will be anchored in two basic premises: • To increase female and minority representation in exempt positions; • To increase female and minority exempt retention. General Guidelines 1. There will be separate goals for: 2. There will be one component for each goal: Overall